Attachment 2 Consultants

Attach-2-consultants.pdf

A multi-center international hospital-based case-control study of lymphoma in Asia (AsiaLymph) (NCI)

Attachment 2 Consultants

OMB: 0925-0654

Document [pdf]
Download: pdf | pdf
Attachment 2: Consultants for AsiaLymph
Outside Consultants
1. Dennis D. Weisenburger, MD
Professor, Director, Hematopathology
Chief Pathologist, Nebraska Lymphoma Study Group
Department of Pathology and Microbiology
University of Nebraska Medical Center
983135 Nebraska Medical Center
Omaha, NE 68198-3135
Tel: 402-559-7688
Fax: 402-559-6018
Email: [email protected]
Dr. Weisenburger is one of the world’s leading lymphoma pathologists and has been
consulted on the study multiple times, most recently in 2010.

2. Shelia Hoar Zahm, Sc.D.
Former Deputy Director
Division of Cancer Epidemiology and Genetics
National Cancer Institute, NIH, DHHS
6120 Executive Boulevard, EPS 8074
Rockville, MD 20892-7242
Tel: (301) 496-8157
Mobile: (301) 502-2090
Fax: (301) 402-3256
Email: [email protected]
Dr. Zahm is one of the world’s leading experts on the epidemiology of lymphoma. She
hasbeen consulted on the study multiple times between 2009-2012. She is currently a
consultant to DCEG.
3. Roel Vermeulen, PhD
Senior Investigator
Institute for Risk Assessment sciences
Utecht Univeristy
Jenalaan 18D
3584 CK Utrecht
The Netherlands
Tel: +030 254 9448
Email: [email protected]
Dr. Vermeulen is an international expert on exposure assessment methods for occupational
and environmental exposure assessment and was consulted multiple times from 2009-2012.

1

4. Troy Sadkowsky
Brisbane, Australia
Email: [email protected]; [email protected]
Mobile: +614 02453168
Mr. Troy Sadkowsky is an expert consultant on computer programming for OccIDEAAS and
has been regularly consulted on the project in 2011 and 2012.
5. John Chan, MD
Consultant Pathologist
Queen Elizabeth Hospital
Wylie Road
Kowloon Hong Kong
Tel: (852) 2958 6830
e-mail: [email protected]
Dr. John Chan is one of the leading lymphoma pathologists in Asia and in the world, who is a
member of the WHO committee on lymphoma classification. He has been consulted on the
study multiple times between 2009 to 2012.
6. Raymond Liang, MD
Director, Comprehensive Oncology Centre
Director, Haematology Centre
Hong Kong Sanatorium & Hospital
2 Village Road, Happy Valley, Hong Kong
Tel : 852-2572 0211
Cell: 852-519-22-313

e-mail: [email protected]
Dr. Liang is one of the leading lymphoma clinicians in Asia and has been consulted multiple
times on the study from 2009-2012.
National Cancer Institute (NCI) Investigators Responsible For Study Management,
Coordination and Statistical Analysis
Qing Lan, Senior Investigator, (301-435-4706)
Lindsay Morton, Investigator, Senior Investigator, (301-435-3972)
Martha Linet, Senior Investigator, (301-496-6600)
Alina Brenner , Staff Scientist, (301-402-8680)
Charles Rabkin, Senior Investigator, (301-435-4731)
Mark Purdue, Senior Investigator, (301-451-5036)
Lynn Goldin, Senior Investigator, (301-402-9656)
Neil Caporaso, Senior Investigator, (301-496-4377)
Stephen Chanock, Senior Investigator, (301-435-7559)
Melissa Friesen, Investigator, (301-594-7485)
Mary Ward, Senior Investigator, (301-435-4713)
Nilanjan Chatterjee, Senior Investigator, (301-496-3358)
Kai Yu, Senior Investigator, (301-594-7206)
Wei Hu, Post-doctoral Fellow, (301-594-1613)
2


File Typeapplication/pdf
File TitleATTACHMENT 1
Authorpctech_temp
File Modified2015-10-14
File Created2015-10-14

© 2024 OMB.report | Privacy Policy